Allergan oral migraine drug succeeds in study
June 11, 2018 at 09:14 AM EDT
June 11 (Reuters) - Allergan Plc said on Monday its oral migraine drug met the main goal across all doses in a study, with a statistically significant reduction in monthly headache days in patients with episodic migraine.